CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 8, 2023 · earnings

AKBA earnings: a negative outcome, -11.9%

On November 8, 2023, Akebia Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.9% in the window around the event. It had already run -6.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.09
1d before
$0.96
Event day
$0.91
1d after
$0.92
5d after

Pre-catalyst setup

-6.4%
30-day run-up
7198%
30-day volatility
1.7×
volume spike